Form 4 for QNCX Quince Therapeutics, Inc.
Accepted 2025-12-08 00:00:00 ET · period of report 2025-12-05 · accession 0000912282-25-001370 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-12-08 | 2025-12-05 | QNCX | Hannah Brendan | COO, CCO, CBO | M - OptEx | $0.9079 | +27.6K | 336.5K | +9% | +$25.0K |
| DM | 2025-12-08 | 2025-12-05 | QNCX | Hannah Brendan | COO, CCO, CBO | M - OptEx | $0.00 | -27.6K | 45.2K | -38% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-12-05 | M | A | 25,280 | $0.94 | 361,827 | D | — | — | |
| 2 | Common | Common Shares | 2025-12-05 | M | A | 2,271 | $0.55 | 336,547 | D | — | — | |
| 3 | Derivative | Employee Stock Option (Right to Buy) | 2025-12-05 | M | D | 25,280 | $0.00 | 199,720 | D | $0.94 · — to 2033-01-31 | 25,280 Common Shares | (F2) Represents grant of 225,000 employee stock options on February 2, 2023, which vest in equal monthly installments at a rate of 1/48th of the total number of shares on each monthly anniversary of the vesting commencement date of January 1, 2023, with full vesting on the fourth annual anniversary of the vesting commencement date. |
| 4 | Derivative | Employee Stock Option (Right to Buy) | 2025-12-05 | M | D | 2,271 | $0.00 | 45,168 | D | $0.55 · — to 2032-05-22 | 2,271 Common Shares | (F1) Represents grant of 103,500 employee stock options on May 19, 2022, which vest over a four-year period, with 25% of the shares subject to the option vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments over the following three years. |